What is the current stock price of Cresco Labs Inc. (CRLBF)?

As of the latest market data, Cresco Labs Inc. (CRLBF) is trading at $0.90. The stock has seen a loss of -1.30% today.

Does Cresco Labs Inc. (CRLBF) pay a dividend?

Based on current data, Cresco Labs Inc. does not have a confirmed active dividend policy.

What is the market cap of Cresco Labs Inc.?

The current market capitalization of Cresco Labs Inc. (CRLBF) is approximately unavailable.

CRLBF

Cresco Labs Inc.·Healthcare

0.90

1.297%(−0.01)

Close Price

Last Updated: — ET

52W L: $0.4352W H: $2.30

CRLBF NEWS

businesswire.com

21h ago

Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances.

zacks.com

May 11

Cresco Labs Inc. (CRLBF) Upgraded to Buy: Here's Why

Cresco Labs Inc. (CRLBF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

businesswire.com

May 11

Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) has announced a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced.

seekingalpha.com

May 8

Cresco Labs Inc. (CRLBF) Q1 2026 Earnings Call Transcript

zacks.com

May 8

Cresco Labs Inc. (CRLBF) Reports Q1 Loss, Beats Revenue Estimates

Cresco Labs Inc. (CRLBF) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.04 per share a year ago.

businesswire.com

May 8

Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiatives

CHICAGO--(BUSINESS WIRE)--Cresco Labs Reports First Quarter 2026 Financial Results.

Company Profile

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of January 27, 2022, it owned and operated 48 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

2,900

IPO Date

2018-12-03

Beta

1.71

Websitewww.crescolabs.com↗